Stay updated with breaking news from Drugs Controller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.
Expert committee to consider SII's emergency use approval for COVID-19 vaccine ANI | Updated: Dec 30, 2020 15:08 IST New Delhi [India], December 30 (ANI): Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official. According to the sources, only Serum Institute's application will be considered. The recommendation of SEC will be sent for drug regulator's approval, later today after the meeting. Covishield ...
According to the sources, only Serum Institute's application will be considered. The recommendation of SEC will be sent for drug regulator's approval later today after the meeting. Covishield is being manufactured on the Chimpanzee Adenovirus platform and by the SII in Pune. The collaborative company is AstraZeneca. "The regulator had allowed the phase 2 and 3 clubbed clinical trials of the vaccine to them and they have applied for emergency use authorisation," he said. The SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global p...
Expert committee to consider Serum Institute's emergency use approval for COVID-19 vaccine The SII is the first indigenous company that has sought emergency approval for the vaccine developed along with global pharma giant AstraZeneca and Oxford University. Share Via Email | A+A A- By ANI NEW DELHI: Subject Expert Committee (SEC) of Drugs Controller of India will take a meeting to consider Serum Institute of India's application for emergency use approval of its COVID-19 vaccine, says a government official. According to the sources, only Serum Institute's application will be conside...